Tizanidine Tablet
Product Images NDC 80425-0187

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Tizanidine (NDC 80425-0187). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Advanced Rx Pharmacy Of Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Fig 1 (Fig 1)

A line graph depicting plasma Tizanidine concentration (ng/mL) over 24 hours post dosing. It compares four conditions: 4 mg Tizanidine tablets with food, without food, and 4 mg capsules with and without food. Concentration peaks around 1-2 hours and declines thereafter under all conditions.*

FDA Label Image

Fig 2 (Fig 2)

A line graph depicting the improvement in Ashworth Score over 6 hours post-dose for three groups: 16 mg tizanidine, 8 mg tizanidine, and placebo. The y-axis represents the improvement score, while the x-axis shows hours after dose. Error bars indicate variability in the data.*

FDA Label Image

Fig 3 (Fig 3)

A line graph with error bars showing improvement in Ashworth Score over three time points: End of Titration (Study Week 3), End of Maintenance (Study Week 7), and Endpoint (Last Observation Carried Forward). The graph compares two groups: one treated with tizanidine (mean dose 28.8 mg) represented by squares, showing greater improvement, and a placebo group represented by circles, showing minimal improvement.*

FDA Label Image

Structure (Structure)

Chemical structure diagram of Tizanidine hydrochloride, displaying the molecular framework with chlorine and nitrogen atoms as part of the structure.*

FDA Label Image

Tizanidine #30 (Tizanidine HCl 2mg Tab Qty 30 Ndc 80425 0187)

Label for Tizanidine HCl 2 mg tablets, NDC 80425-0187-01, manufactured by Advanced Rx Pharmacy of Tennessee, LLC, Nashville, TN. The label includes a barcode, lot number 30TIZ2123, expiration date 1/31/2022, and storage directions to keep the product at room temperature between 20°C and 25°C (68°F - 77°F). It also contains a caution that federal law prohibits transfer of the drug to anyone other than the prescribed patient.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.